A lubricious formulation exhibiting reduced thrombogenicity, cell proliferation, and protein adsorption

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 90 B, Issue 1, 2009, Pages 452-460

  Vicario, Pasquale P ^a   Lu, Zichun J ^a   Grigorian, Irina A ^a   Schottman, Tom ^a  

^a Hydromer Inc   (United States)

Author keywords

Cell proliferation; Platelet adhesion; Polyurethane tubing; Stainless steel; Thrombogenicity

Indexed keywords

ADHESION; ADSORPTION; ANTIBODIES; BLOOD; BLOOD SUBSTITUTES; CELL MEMBRANES; CELL PROLIFERATION; CORROSION RESISTANT ALLOYS; ENDOTHELIAL CELLS; MICROSCOPIC EXAMINATION; PLATELETS; TUBING;

BLOOD COMPONENT; CORONARY STENTS; ELECTROPOLISHED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUVEC CELLS; IMMUNOHISTOCHEMICAL METHODS; MEDICAL DEVICES; PLASMA PROTEIN; PLATELET ADHESION; PROTEIN ADSORPTION; RESTENOSIS; TEAR FLUID; THROMBOGENICITY; THROMBUS FORMATION; WHOLE BLOOD;

STAINLESS STEEL;

CD15 ANTIGEN; CD235 ANTIGEN; FIBRINOGEN RECEPTOR; LYMPHOCYTE ANTIGEN; LYSOZYME; POLYURETHAN; STAINLESS STEEL; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; BLOOD COMPONENT; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROCYTE ADHESIVENESS; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LACRIMAL FLUID; LEUKOCYTE ADHERENCE; THROMBOCYTE ADHESION; THROMBOGENICITY;

ADSORPTION; ANTIGENS, CD; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEINS; THROMBOSIS;

EID: 67650786820     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31306     Document Type: Article

References (34)

1. Verheye S, Markou CP, Salame MY, Wan B, King SB III, Robinson KA, Chronos NAF, Hanson SR. Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Arterioscler Thromb Vasc Biol 2000;20:1168-1172. (Pubitemid 30207598)
2. De Scheerder I, Wang K, Wilczek K, Meuleman D, Van Amsterdam R, Vogel G, Piessens J, Van de Werf F. Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation 1997;95:1549-1553. (Pubitemid 27142814)
3. Meyer J. Substantial reduction of platelet adhesion by heparin- coated stents. J Interv Cardiol14:407-413.
4. Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Columbo A, Seabra- Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugman S, Morel MA. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease. Lancet 1998;52:673-681. (Pubitemid 28398701)
5. Mehran R, Aymong ED, Ashby DR, Fischell T, Whitworth H Jr, Siegel R, Thomas W, Wong SC, Narasimaiah R, Lansky AJ, Leon MB. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent. Circulation 2003;108:1078-1083.
6. Maalej N, Albrecht R, Loscalzo J, Folts JD. The potent platelet inhibitory effects of S-nitrosated albumin coating of artifi- cial surfaces. J Am Coll Cardiol 1999;33:1408-1414.
7. Alt E, Seliger C. Antithrombotic stent coatings: Hirudin/iloprost combination. Semin Interv Cardiol 1998;3:177-1173
8. Jonasson L, Holm J, Hansson GK. Cyclosporine A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci USA 1988;85:2303-2306. (Pubitemid 24315879)
9. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystineinduced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976;58: 731-741.
10. Serebruany VL, Malinin AI, Jerome SD, Lowry DR, Morgan AW, Sane DC, Tanquay JF, Steinhubl SR, O'connor CM. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: The plavix use for treatment of congestive heart failure (PLUTO-CHF) trial. Am Heart J 2003;146:713-720.
11. Dangas G, Kuepper F. Restenosis: Repeat narrowing of a coronary artery. Circulation 2002;105:2586-2587.
12. Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A. Long-term safety and efficacy of drug-eluting stents. Two year results of the REAL (Registry AngiopLastiche dell'Emilia Romagna) Multicenter Registry. Circulation 2007;115:3181-3188.
13. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME. TAXUS I. Six- and twelve-month results from a randomized double-blind trial on a slow release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42. (Pubitemid 36070930)
14. Degertekin M, Serruys PW, Foley DP, Tanabe K, Regar E, Vos J, Smits PC, van der Giessen WJ, van den Brand M, de Feyter P, Popma JJ. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2002;106:1610-1613.
15. Maisel WH, Laskey WK. Drug-eluting stents. Circulation 2007;115:e426-e427.
16. Vicario P, Lu Z, Wang Z, Merritt K, Buongiovanni D, Chen P. Anti-thrombogenicity of Hydromer's polymeric formula F202 immobilized on polyurethane and electropolished stainless steel. J Biomed Mater Res Part B 2008;86B:136-144. (Pubitemid 351874377)
17. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature 1993;362:801-809.
18. Wang TH, Wang HS, Soong YK. Pacilitaxel-induced cell death: Where the cell cycle and apoptosis come together. Cancer 2000;88:2619-2628.
19. Cannan CR. Anti-thrombogenic therapy in cardiac stent patients. Curr Cardiol Rep 2001;3:78-84.
20. Niimi Y, Ichinose F, Ishiguro Y, Terui K, Uezono S, Morita S, Yamane S. The effects of heparin coating of oxygenator fibers on platelet adhesion and protein adsorption. Anesth Analg 1999;89:573-579. (Pubitemid 29409799)
21. Anderson AB, Tran TH, Hamilton MJ, Chudzik SJ, Hastings BP, Melchior MJ, Hergenrother RW. Platelet deposition and fibrinogen binding on surfaces coated with heparin or frictionreducing polymers. ANJR Am J Neuroradiol 1996;17:859-863.
22. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt T, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002;196:887-896.
23. Takemoto S, Yamamoto T, Tsuru K, Hayakawa S, Osaka A. Platelet adhesion on metal oxide layers. Key Eng Mater 2004;254-256:853-856.
24. Hayakawa S, Tsuru K, Osaka A. Platelet adhesion on titania film prepared from the interaction of Ni-Ti alloy with hydrogen peroxide solution. Key Eng Mater 2004;254-256:865-868.
25. Suggs JJ, West JL, Mikos AG. Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer. Biomaterials 1999;20:683-690.
26. Aldenhoff YBJ, Koole LH. Platelet adhesion studies on dipyridamole coated polyurethane surfaces. Eur Cells Mater 2003;5:61-67. (Pubitemid 38957402)
27. Yuan J, Zhang J, Zhou J, Shen J, Lin SC. Platelet adhesion onto segmented polyurethane surfaces modified by carboxybetaine. J Biomater Sci Polym Ed 2003;14:1339-1349. (Pubitemid 38028747)
28. Knoner G, Rolfe BE, Campbell JH, Parkin SJ, Heckenberg NR, Rubinstein-Dunlop H. Biophys J 2006;91:3085-3096.
29. Alibeik S, Sheardown H, Rizhalla AS, Mequanint K. Protein adsorption and platelet adhesion onto ion-containing polyurethanes. J Biomater Sci Polymer Ed 2007;18:1195-1210. (Pubitemid 47556683)
30. Farris RL. Tear analysis in contact lens wearers. Trans Am Ophthalmol Soc 1985;83:501-545. (Pubitemid 17210930)
31. Baines M, Cai F, Backman H. Adsorption and removal of protein bound to hydrogel contact lenses. Optom Vis Sci 1990;67:807-810. (Pubitemid 20385548)
32. Bohnert JL, Horbett TA, Ratner BD, Royce FH. Adsorption of proteins from artificial tear solutions to contact lens materials. Invest Ophthalmol Vis Sci 1988;29:362-373.
33. Leahy DD, Mandell R, Lin S. Initial in-vivo tear protein deposition on individual hydrogel contact lenses. Optom Vis Sci 1990;67:504-511. (Pubitemid 20289224)
34. Mondino B, Salamon S, Zaidman G. Allergic and toxic reactions in soft contact lens wearers. Surv Ophthalmol 1982;26: 337-344. (Pubitemid 12080982)